Cargando…

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds

BACKGROUND: Increased knowledge of the evolution of molecular changes in neurodegenerative disorders such as Alzheimer’s disease (AD) is important for the understanding of disease pathophysiology and also crucial to be able to identify and validate disease biomarkers. While several biological change...

Descripción completa

Detalles Bibliográficos
Autores principales:	Remnestål, Julia, Bergström, Sofia, Olofsson, Jennie, Sjöstedt, Evelina, Uhlén, Mathias, Blennow, Kaj, Zetterberg, Henrik, Zettergren, Anna, Kern, Silke, Skoog, Ingmar, Nilsson, Peter, Månberg, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923505/ https://www.ncbi.nlm.nih.gov/pubmed/33653397 http://dx.doi.org/10.1186/s13195-021-00789-5

Ejemplares similares

Association between serum urate and CSF markers of Alzheimer's disease pathology in a population‐based sample of 70‐year‐olds
por: Fatima, Tahzeeb, et al.
Publicado: (2021)

Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐olds
por: Dittrich, Anna, et al.
Publicado: (2022)

A Western‐style dietary pattern is associated with cerebrospinal fluid biomarker levels for preclinical Alzheimer's disease—A population‐based cross‐sectional study among 70‐year‐olds
por: Samuelsson, Jessica, et al.
Publicado: (2021)

A Non-APOE Polygenic Risk Score for Alzheimer’s Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds
por: Skoog, Ingmar, et al.
Publicado: (2021)

Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
por: Zettergren, Anna, et al.
Publicado: (2019)

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
por: Remnestål, Julia, et al.
Publicado: (2020)

Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study
por: Rådestig, Maya Arvidsson, et al.
Publicado: (2023)

Genetic Variation in FOXO3 is Associated with Self-Rated Health in a Population-Based Sample of Older Individuals
por: Zettergren, Anna, et al.
Publicado: (2018)

Interactions between dietary patterns and genetic factors in relation to incident dementia among 70-year-olds
por: Samuelsson, Jessica, et al.
Publicado: (2021)

Sex differences in CSF biomarkers for neurodegeneration and blood‐brain barrier integrity
por: Skillbäck, Tobias, et al.
Publicado: (2021)

Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg
por: Dittrich, Anna, et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults
por: Badji, Atef, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
por: Arvidsson Rådestig, Maya, et al.
Publicado: (2023)

Reply to “Pathway for ascertaining the role of uric acid in neurodegenerative diseases,” Roman Youssef
por: Dehlin, Mats, et al.
Publicado: (2022)

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
por: Bergström, Sofia, et al.
Publicado: (2021)

Reproductive period and preclinical cerebrospinal fluid markers for Alzheimer disease: a 25-year study
por: Najar, Jenna, et al.
Publicado: (2021)

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems
por: Kern, Silke, et al.
Publicado: (2018)

Slowing gait speed precedes cognitive decline by several years
por: Skillbäck, Tobias, et al.
Publicado: (2022)

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
por: Remnestål, Julia, et al.
Publicado: (2016)

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K, et al.
Publicado: (2017)

Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K., et al.
Publicado: (2018)

Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years
por: Skoog, Ingmar, et al.
Publicado: (2016)

Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE ɛ4
por: Hasselgren, Caroline, et al.
Publicado: (2018)

Passive and active suicidal ideation in a population-based sample of older adults: Associations with polygenic risk scores of relevance for suicidal behavior
por: Zettergren, Anna, et al.
Publicado: (2023)

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures
por: Mielke, Michelle M., et al.
Publicado: (2019)

Low Cerebrospinal Fluid Aβ(42) and Aβ(40) are Related to White Matter Lesions in Cognitively Normal Elderly
por: Skoog, Ingmar, et al.
Publicado: (2018)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
por: Henjum, Kristi, et al.
Publicado: (2018)

Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia
por: Marseglia, Anna, et al.
Publicado: (2021)

Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives
por: Najar, Jenna, et al.
Publicado: (2021)

Association of Single Nucleotide Polymorphisms Located in LOXL1 with Exfoliation Glaucoma in Southwestern Sweden
por: Ayala, Marcelo, et al.
Publicado: (2021)

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
por: Fossati, Silvia, et al.
Publicado: (2019)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
por: Dong, Ruocheng, et al.
Publicado: (2021)

Time trends in nutrient intake and dietary patterns among five birth cohorts of 70-year-olds examined 1971–2016: results from the Gothenburg H70 birth cohort studies, Sweden
por: Samuelsson, Jessica, et al.
Publicado: (2019)

(18)F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
por: Leuzy, Antoine, et al.
Publicado: (2019)

Comparing (18)F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
por: Mattsson, Niklas, et al.
Publicado: (2018)

The Gothenburg H70 Birth cohort study 2014–16: design, methods and study population
por: Rydberg Sterner, Therese, et al.
Publicado: (2018)

Depression in relation to sex and gender expression among Swedish septuagenarians—Results from the H70 study
por: Rydberg Sterner, Therese, et al.
Publicado: (2020)

Longstanding smoking associated with frontal brain lobe atrophy: a 32-year follow-up study in women
por: Johansson, Lena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gu3fblpg08a6m66anadrvnftvs